Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005012
What this trial is testing

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Who this might be right for
HIV Infections
Schering-Plough 250
Not applicableUnknownNCT03618407
What this trial is testing

Effect of Early Antiviral Therapy on Duration of Cough in Flu Patients

Who this might be right for
Influenza Virus Infection
Renmin Hospital of Wuhan University 120
Testing effectiveness (Phase 2)Study completedNCT00915655
What this trial is testing

Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Who this might be right for
HIV-1 Infection
Tibotec Pharmaceuticals, Ireland 12
Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06452693
What this trial is testing

A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 162
Testing effectiveness (Phase 2)Study completedNCT00120835
What this trial is testing

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableUnknownNCT05372874
What this trial is testing

Treatment of Hepatitis c by Using Direct-acting Antiviral

Who this might be right for
Hepatitis C
Tanta University 50
Not applicableEnded earlyNCT03164889
What this trial is testing

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Beijing 302 Hospital 80
Large-scale testing (Phase 3)Study completedNCT01674725
What this trial is testing

Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 187
Post-approval studies (Phase 4)UnknownNCT00872417
What this trial is testing

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Who this might be right for
Acquired Immune Deficiency SyndromeHIV Infections
Peking Union Medical College 750
Testing effectiveness (Phase 2)Study completedNCT03045861
What this trial is testing

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 33
Post-approval studies (Phase 4)Ended earlyNCT00488059
What this trial is testing

Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05597735
What this trial is testing

Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease

Who this might be right for
MonkeypoxMpox
ANRS, Emerging Infectious Diseases 480
Early research (Phase 1)Study completedNCT01582035
What this trial is testing

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Who this might be right for
Hepatitis C
Janssen R&D Ireland 7
Testing effectiveness (Phase 2)Looking for participantsNCT07670468
What this trial is testing

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
BKV InfectionEBV InfectionCMV Infection
LucasBio 27
Testing effectiveness (Phase 2)Ended earlyNCT00242879
What this trial is testing

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 130
Testing effectiveness (Phase 2)Study completedNCT00002213
What this trial is testing

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 80
Testing effectiveness (Phase 2)WithdrawnNCT04536090
What this trial is testing

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

Who this might be right for
COVID-19
Institut de Recherches Cliniques de Montreal
Testing effectiveness (Phase 2)Looking for participantsNCT06222723
What this trial is testing

LAssa Fever Adjunct Treatment With DEXamethasone

Who this might be right for
Lassa Fever
Bernhard Nocht Institute for Tropical Medicine 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT07225959
What this trial is testing

Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)

Who this might be right for
Healthy Participants
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 400
Next Page